Exploring the therapeutic applications of low-dose psychedelic compounds in modern neuropsychiatry requires a thorough examination of clinical pharmacology, neuroplasticity, and mood regulation pathways. Across an international community spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, researchers, clinicians, and individuals navigating alternative health paradigms frequently analyze […]